Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
The development of therapeutic resistance to targeted anticancer therapies remains a
significant clinical problem, with intratumoral heterogeneity playing a key role. In this context …
significant clinical problem, with intratumoral heterogeneity playing a key role. In this context …
Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies
Breast cancer is highly prevalent in females and accounts for second highest number of
deaths, worldwide. Cumbersome, expensive and time consuming detection techniques …
deaths, worldwide. Cumbersome, expensive and time consuming detection techniques …
Electrochemical nanobiosensors for detection of breast cancer biomarkers
This comprehensive review paper describes recent advances made in the field of
electrochemical nanobiosensors for the detection of breast cancer (BC) biomarkers such as …
electrochemical nanobiosensors for the detection of breast cancer (BC) biomarkers such as …
Quantitative digital histopathology and machine learning to predict pathological complete response to chemotherapy in breast cancer patients using pre-treatment …
Complete pathological response (pCR) to neoadjuvant chemotherapy (NAC) is a prognostic
factor for breast cancer (BC) patients and is correlated with improved survival. However …
factor for breast cancer (BC) patients and is correlated with improved survival. However …
Self-calibrating on-chip localized surface plasmon resonance sensing for quantitative and multiplexed detection of cancer markers in human serum
The need for point-of-care devices able to detect diseases early and monitor their status, out
of a lab environment, has stimulated the development of compact biosensing configurations …
of a lab environment, has stimulated the development of compact biosensing configurations …
Expression of CDK8 and CDK8-interacting genes as potential biomarkers in breast cancer
CDK8 and its paralog CDK19, in complex with CCNC, MED12 and MED13, are
transcriptional regulators that mediate several carcinogenic pathways and the …
transcriptional regulators that mediate several carcinogenic pathways and the …
Challenges and opportunities in clinical applications of blood-based proteomics in cancer
Simple Summary The traditional approach in identifying cancer related protein biomarkers
has focused on evaluation of a single peptide/protein in tissue or circulation. At best, this …
has focused on evaluation of a single peptide/protein in tissue or circulation. At best, this …
Blood-based protein biomarkers in breast cancer
C Núñez - Clinica Chimica Acta, 2019 - Elsevier
Breast cancer (BCa) is a significant healthcare problem on women worldwide. Thus, early
detection is very important to reduce mortality. Furthermore, better BCa prognosis could …
detection is very important to reduce mortality. Furthermore, better BCa prognosis could …
Cadherins: the superfamily critically involved in breast cancer
M Afzal Ashaie… - Current pharmaceutical …, 2016 - ingentaconnect.com
Breast cancer, one of the leading causes of mortality and morbidity among females, is
regulated in part by diverse classes of adhesion molecules one of which is known as …
regulated in part by diverse classes of adhesion molecules one of which is known as …
[HTML][HTML] Cancer: we should not forget the past
A Di Lonardo, S Nasi, S Pulciani - Journal of cancer, 2015 - ncbi.nlm.nih.gov
Cancer has been in existence longer than human beings, and man has been facing the
illness ever since he made his appearance on Earth. Amazingly, the first human cancer …
illness ever since he made his appearance on Earth. Amazingly, the first human cancer …